Medical Device GTM • Evidence • SEO • KOL Education • ABM

Medical Device Marketing Agency

RAASIS Technology helps medical device manufacturers, MedTech startups, diagnostics and IVD companies, surgical-device teams, digital-device brands and distributors turn intended use, clinical evidence, technical performance and economic value into qualified commercial demand. Our work connects claims governance, medical device SEO, AI-search source readiness, KOL education, hospital ABM, launches, channel enablement and accountable pipeline measurement.

Evidence-led commercialization system

Turn intended use and proof into qualified adoption demand.

GLOBAL

RAASIS Device OS

Adoption journey

Status → Evidence → Champion → Committee → Adoption

Clinical case

Outcomes + safety

Economic case

Workflow + value

Discover
Evaluate
Adopt
Claims governance KOL education Hospital ABM Channel enablement Pipeline
StatusMarket-specific launch language and approval context
EvidenceClinical, technical and health-economic proof architecture
DemandSearch, education, events, accounts and channel activation
PipelineQualified accounts, demos, evaluations and adoption stages
Medical Device SEOEvidence HubsKOL EducationHospital ABM
Trade Show DemandDistributor EnablementClaims GovernanceAI Search Readiness

Direct answer

What does a medical device marketing agency do?

A medical device marketing agency translates a device’s intended use, regulatory status, evidence, workflow fit and economic value into credible market education and qualified commercial demand. The work spans positioning, product and evidence content, search visibility, AI discovery, clinical education, hospital buying committees, launch campaigns, distributors, sales enablement and pipeline analytics. Every public claim should remain traceable to approved evidence and the manufacturer’s market-specific medical, legal and regulatory review.

Prove

Clinical + technical evidence

Translate

Value by stakeholder

Activate

Qualified adoption pipeline

Evidence-to-adoption content system

Commercialization content built for evidence, committees and adoption.

Medical devices are evaluated through clinical, technical, operational, economic and regulatory lenses. The content system must answer each buyer’s questions without overstating the device or fragmenting the commercial story.

Medical device claims matrix and market-specific regulatory review workflow

Claims and status governance

Make every public claim traceable to approved evidence.

RAASIS organizes intended use, indications, regulatory status, warnings, performance evidence, comparison boundaries and market-specific review owners into a practical claims system.

  • Claims matrix linking each message to evidence, source material and approval owner
  • Regulatory-status language by geography, audience, product stage and channel
  • Medical, legal, regulatory and brand review workflow for pages, ads and sales assets

Evidence and source architecture

Build a source library buyers and search systems can verify.

We translate clinical, technical and health-economic evidence into useful product education without turning study results into claims the source material cannot support.

  • Evidence hub with study design, population, endpoints, limitations and references
  • Product, procedure, workflow, safety, interoperability, training and comparison pages
  • Direct-answer modules with expert review, dates, citations and controlled documents
Medical device evidence hub with clinical technical and economic source content
Medical device KOL education webinar and congress content programme

Clinical education and KOL programmes

Enable peer learning without turning education into hype.

We design expert-led programmes around approved topics, transparent roles and useful clinical education, then connect engagement to account follow-up and sales enablement.

  • KOL selection by specialty, evidence fit, audience relevance and conflict review
  • Webinars, workshops, congress content, interviews and case-based education
  • Consent, disclosure, review, repurposing and CRM handoff governance

Hospital ABM and buying committees

Give every stakeholder the proof needed to move the account.

We map clinical champions, department heads, procurement, finance, IT, biomedical engineering, infection control and executives to distinct questions, objections and decision assets.

  • Target-account journeys, role-specific landing pages and nurture sequences
  • Value-analysis dossier, implementation plan, budget impact and security package
  • Account engagement, demo, evaluation, procurement and adoption-stage tracking
Medical device hospital account based marketing and buying committee journey
Medical device trade show distributor enablement and lifecycle demand system

Trade shows, distributors and lifecycle

Convert events and channel activity into repeatable market development.

We connect pre-event demand, meetings, booth engagement, distributor enablement, training and post-event follow-up to one measurable commercial pipeline.

  • Meeting campaigns, QR capture, demo workflows and rapid lead routing
  • Distributor onboarding, localized campaign kits, training and certification
  • Adoption, service, reorder, renewal and account-expansion communication

A–Z MedTech commercialization blueprint

Twenty-six controls for credible medical device growth.

A durable medical device growth system aligns evidence, claims, product information, buyer education, channel execution and revenue measurement across markets and teams.

A

Account selection

Prioritize health systems, specialties, clinics, labs, distributors and buying groups by fit, need and access.

B

Buying committee

Map clinical, operational, technical, financial and procurement roles before building campaigns.

D

Device entity clarity

Keep product name, manufacturer, intended use, model, market status and documentation consistent.

E

Evidence hub

Organize clinical, technical, safety, usability and economic evidence into a controlled source library.

G

Geographic governance

Adapt status, claims, language, privacy, promotion and channel rules for each target market.

H

Health-economic value

Explain workflow impact, resource use, budget implications and value-analysis assumptions transparently.

I

Intended-use clarity

State who uses the device, for what purpose, in which setting and under what boundaries.

J

Journey analytics

Measure content, account and stakeholder progression instead of counting anonymous clicks alone.

L

Launch readiness

Align status language, evidence assets, product pages, training, CRM and channel materials before launch.

M

Market access

Support reimbursement, coding, procurement, value analysis and implementation conversations with evidence.

N

Narrative discipline

Use one defensible category story across website, sales, congress, distributor and investor materials.

O

Onboarding and adoption

Provide implementation guides, training, competency support, FAQs and success checkpoints.

P

Product information architecture

Connect intended use, specifications, evidence, safety, downloads, support and demo paths.

Q

Qualified demand

Define quality by account fit, stakeholder role, need, timing and next commercial action.

S

Search and AI visibility

Build crawlable source pages with direct answers, original expertise, references and clear entities.

T

Trade-show conversion

Plan meetings, capture context, route leads and trigger fast role-specific follow-up.

U

User training

Turn correct use, workflow integration and troubleshooting into accessible education assets.

V

Value-analysis dossier

Package clinical, operational, economic, implementation and vendor evidence for committee review.

X

Cross-functional review

Connect marketing, medical, regulatory, legal, quality, cybersecurity and commercial owners.

Y

YMYL evidence controls

Use qualified reviewers, reliable sources, careful language, dates and visible limitations.

Z

Zero-friction next step

Offer the right action: evidence download, expert question, demo, evaluation or distributor contact.

Medical device marketing services

An evidence-to-adoption commercial system.

RAASIS connects go-to-market strategy, claims governance, search, evidence content, expert education, hospital accounts, channel activation and pipeline analytics into one accountable programme.

01 / GTM

Commercial strategy and ICP

Category positioning, market segmentation, buying-committee mapping, launch priorities and commercialization roadmap.

03 / Discovery

Medical device SEO + AI search

Technical SEO, intent architecture, source-grade pages, entity clarity and answer-led content for qualified discovery.

04 / Evidence

Clinical, technical and value content

Evidence hubs, product pages, study summaries, workflow assets, value dossiers, comparisons and training resources.

05 / Education

KOL and clinical education

Expert webinars, congress content, interviews, workshops and peer-learning programmes with transparent governance.

06 / Accounts

Hospital ABM and sales enablement

Target-account journeys, stakeholder assets, value-analysis materials, demo nurture and champion development.

07 / Activation

Launch, events and channel enablement

Launch campaigns, trade-show conversion, distributor kits, regional assets, training and lifecycle communication.

08 / Intelligence

Pipeline measurement and optimization

Qualified accounts, demos, evaluations, procurement stages, channel activity, adoption and attributed pipeline.

Commercialization-stage playbook

Different evidence and demand motions at every stage.

Pre-market preparation, launch readiness, early adoption and expansion require different public language, proof assets, buying journeys and success measures.

Stage 01

Pre-market foundation

Build category education, evidence architecture, KOL mapping, search foundations and unambiguous status language before broad promotion.

Stage 03

Early adoption

Develop champions, evaluation support, implementation content, case evidence, peer education and objection-handling assets.

Stage 04

Scale and expansion

Expand accounts, specialties, geographies and channels with localized governance, ABM, lifecycle programmes and board-ready analytics.

MedTech discovery, evidence and revenue stack

One operating view from source page to adopted account.

The exact platform mix depends on market, audience and data sensitivity. RAASIS configures crawlable content, policy-aware acquisition, controlled evidence, account workflows and dashboards around the device’s commercial model.

SC

Search Console

Search demand, indexation, source pages and generative-AI reporting where available.

GA4

GA4

Evidence engagement, downloads, demos, webinar registrations and key journey events.

GAds

Google Ads

Policy- and market-eligibility-aware search campaigns around qualified professional or product intent.

IN

LinkedIn Ads

Professional audience, role and account programmes for HCP and B2B buying journeys.

YT

YouTube

Approved product education, workflow demonstrations, expert discussion and training content.

CRM

CRM

Accounts, stakeholders, demos, evaluations, procurement, distributor activity and adoption stages.

ABM

ABM Tools

Account selection, buying-committee coverage, engagement signals and coordinated plays.

SD

Schema.org

Applicable Organization, Service, Product, Video and Breadcrumb markup matched to visible content.

AI

AI Search

Direct answers, entity clarity, expert-led sources, references and non-commodity evidence content.

REG

Review Workflow

Version control, evidence links, status language and medical, legal and regulatory approvals.

EV

Evidence Library

Controlled studies, technical documents, safety material, value assets and training sources.

LS

Looker Studio

Qualified demand, account progression, channel contribution, sales cycle and pipeline reporting.

Why RAASIS for medical device marketing?

Commercial growth needs evidence discipline and buying-journey depth.

01 / Governance

Claims-governed content operations

We connect messages to evidence, market status and accountable review owners. Final regulatory and legal approval remains with the client.

02 / Translation

Evidence buyers can understand

We turn complex studies, specifications, workflow data and economics into useful stakeholder-specific source assets.

03 / Committees

Buying-committee journey design

We build distinct pathways for clinicians, procurement, finance, IT, engineering, executives and channel partners.

04 / Discovery

Search and AI source readiness

We create crawlable, expert-led pages with direct answers, clear entities, sources and useful depth—not AI-search shortcuts.

05 / Activation

Launch and channel integration

We align website, education, paid campaigns, events, sales content, distributors, training and lifecycle follow-up.

06 / Measurement

Commercial-stage analytics

We measure qualified accounts, stakeholder engagement, demos, evaluations, procurement progress, adoption and pipeline.

Medical device growth workflow

Audit. Govern. Build. Activate. Optimize.

The programme moves through controlled decisions so product status, evidence, audiences, channels and measurement remain aligned as the commercial system expands.

Step 1

Audit

Review markets, status, intended use, evidence, competitors, search demand, stakeholders, channels and analytics.

Step 2

Govern

Create the claims matrix, evidence map, status language, review owners, privacy rules and publishing workflow.

Step 3

Build

Develop the source architecture, product and evidence pages, buyer assets, landing pages, CRM and measurement plan.

Step 4

Activate

Launch approved SEO, expert education, account programmes, paid campaigns, events and distributor plays.

Step 5

Optimize

Improve account quality, content utility, demo conversion, evaluation support, channel performance and adoption signals.

Medical device category use cases

Commercial systems adapted to the device and buying pathway.

The right strategy changes with device risk, care setting, evidence model, user, purchaser, implementation burden, channel structure and market status.

Surgical and procedural devices

Technique education, clinical workflow, KOL demonstration, evidence, training and procedure-specific buying journeys.

Capital equipment

Value analysis, utilization, service, installation, training, infection control, financing and procurement enablement.

SaMD and connected devices

Clinical purpose, cybersecurity, interoperability, data governance, implementation, integration and IT buyer confidence.

Monitoring and wearables

Signal quality, workflow, adherence, privacy, alert management, patient education and reimbursement context.

Dental and implant devices

Clinician education, procedure adoption, evidence, distributor enablement, training and patient-support content.

Aesthetic medical devices

Provider education, claim and visual governance, safety context, differentiation, demos and practice-development support.

MedTech scaleups

Multi-market SEO, account expansion, distributor governance, localized evidence, portfolio architecture and board reporting.

Medical device marketing FAQs

Decision-ready answers.

Start with an evidence-to-demand audit

Build the commercial system your device deserves.